FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
美国食品药品监督管理局称关键试验存在“操纵”，玷污了对ChemoCentryx药物的批准

The FDA accused ChemoCentryx of manipulating the results of a pivotal clinical trial used to approve the drug Tavneos, escalating the agency’s effort to pull the treatment from the market.
美国食品药品监督管理局指控ChemoCentryx操纵用于批准药物Tavneos的一项关键性临床试验结果，进一步升级其将该疗法撤出市场的行动。